123 related articles for article (PubMed ID: 35373558)
21. Effects of sialic acid residues of transferrin on the binding with aluminum and iron studied by HPLC/high-resolution ICP-MS.
Nagaoka MH; Maitani T
Biochim Biophys Acta; 2001 May; 1526(2):175-82. PubMed ID: 11325539
[TBL] [Abstract][Full Text] [Related]
22. Periodate modification of human serum transferrin Fe(III)-binding sites. Inhibition of carbonate insertion into Fe(III)- and Cu(II)-chelator-transferrin ternary complexes.
Ross DC; Egan TJ; Purves LR
J Biol Chem; 1995 May; 270(21):12404-10. PubMed ID: 7759481
[TBL] [Abstract][Full Text] [Related]
23. Vanadium(V/IV)-Transferrin Binding Disrupts the Transferrin Cycle and Reduces Vanadium Uptake and Antiproliferative Activity in Human Lung Cancer Cells.
Levina A; Lay PA
Inorg Chem; 2020 Nov; 59(22):16143-16153. PubMed ID: 32578416
[TBL] [Abstract][Full Text] [Related]
24. Holo/apo conversion two-dimensional urea PAGE for speciation of Fe
Saito S; Ishikawa J; Ono M; Tasaki-Handa Y; Shibukawa M
Anal Sci; 2024 Feb; 40(2):227-233. PubMed ID: 37966577
[TBL] [Abstract][Full Text] [Related]
25. Ferric ions release from iron-binding protein: Interaction between acrylamide and human serum transferrin and the underlying mechanisms of their binding.
He F; Wang J; Yuan D; Liu Y; Liu R; Zong W
Sci Total Environ; 2022 Nov; 847():157583. PubMed ID: 35882343
[TBL] [Abstract][Full Text] [Related]
26. Metal retention in human transferrin: consequences of solvent composition in analytical sample preparation methods.
Quarles CD; Randunu KM; Brumaghim JL; Marcus RK
Metallomics; 2011 Oct; 3(10):1027-34. PubMed ID: 21904748
[TBL] [Abstract][Full Text] [Related]
27. A molecular docking study of the interactions between human transferrin and seven metallocene dichlorides.
Güette-Fernández JR; Meléndez E; Maldonado-Rojas W; Ortega-Zúñiga C; Olivero-Verbel J; Parés-Matos EI
J Mol Graph Model; 2017 Aug; 75():250-265. PubMed ID: 28609757
[TBL] [Abstract][Full Text] [Related]
28. Kinetic studies on the removal of iron and aluminum from recombinant and site-directed mutant N-lobe half transferrins.
Li Y; Harris WR; Maxwell A; MacGillivray RT; Brown T
Biochemistry; 1998 Oct; 37(40):14157-66. PubMed ID: 9760252
[TBL] [Abstract][Full Text] [Related]
29. An iron-dependent and transferrin-mediated cellular uptake pathway for plutonium.
Jensen MP; Gorman-Lewis D; Aryal B; Paunesku T; Vogt S; Rickert PG; Seifert S; Lai B; Woloschak GE; Soderholm L
Nat Chem Biol; 2011 Jun; 7(8):560-5. PubMed ID: 21706034
[TBL] [Abstract][Full Text] [Related]
30. Zinc mediates the interaction between ceruloplasmin and apo-transferrin for the efficient transfer of Fe(III) ions.
Sakajiri T; Nakatsuji M; Teraoka Y; Furuta K; Ikuta K; Shibusa K; Sugano E; Tomita H; Inui T; Yamamura T
Metallomics; 2021 Dec; 13(12):. PubMed ID: 34791391
[TBL] [Abstract][Full Text] [Related]
31. Ligand variation in the transferrin family: the crystal structure of the H249Q mutant of the human transferrin N-lobe as a model for iron binding in insect transferrins.
Baker HM; Mason AB; He QY; MacGillivray RT; Baker EN
Biochemistry; 2001 Oct; 40(39):11670-5. PubMed ID: 11570867
[TBL] [Abstract][Full Text] [Related]
32. Redox potentials of Ti(IV) and Fe(III) complexes provide insights into titanium biodistribution mechanisms.
Parker Siburt CJ; Lin EM; Brandt SJ; Tinoco AD; Valentine AM; Crumbliss AL
J Inorg Biochem; 2010 Sep; 104(9):1006-9. PubMed ID: 20569990
[TBL] [Abstract][Full Text] [Related]
33. The thermodynamic and binding properties of the transferrins as studied by isothermal titration calorimetry.
Bou-Abdallah F; Terpstra TR
Biochim Biophys Acta; 2012 Mar; 1820(3):318-25. PubMed ID: 21843602
[TBL] [Abstract][Full Text] [Related]
34. Unusual Synergism of Transferrin and Citrate in the Regulation of Ti(IV) Speciation, Transport, and Toxicity.
Tinoco AD; Saxena M; Sharma S; Noinaj N; Delgado Y; Quiñones González EP; Conklin SE; Zambrana N; Loza-Rosas SA; Parks TB
J Am Chem Soc; 2016 May; 138(17):5659-65. PubMed ID: 27070073
[TBL] [Abstract][Full Text] [Related]
35. The bicarbonate-dependence of zinc(II)-transferrin binding.
Harris WR; Stenback JZ
J Inorg Biochem; 1988 Jul; 33(3):211-23. PubMed ID: 2843602
[TBL] [Abstract][Full Text] [Related]
36. X-ray Characterization of Conformational Changes of Human Apo- and Holo-Transferrin.
Campos-Escamilla C; Siliqi D; Gonzalez-Ramirez LA; Lopez-Sanchez C; Gavira JA; Moreno A
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948188
[TBL] [Abstract][Full Text] [Related]
37. Organ distribution and pharmacokinetics of titanium after treatment with titanocene dichloride.
Köpf-Maier P; Brauchle U; Henssler A
Toxicology; 1988 Oct; 51(2-3):291-8. PubMed ID: 3176032
[TBL] [Abstract][Full Text] [Related]
38. A proposed mechanism for the inhibitory effect of the anticancer agent titanocene dichloride on tumour gelatinases and other proteolytic enzymes.
Pavlaki M; Debeli K; Triantaphyllidou IE; Klouras N; Giannopoulou E; Aletras AJ
J Biol Inorg Chem; 2009 Aug; 14(6):947-57. PubMed ID: 19390879
[TBL] [Abstract][Full Text] [Related]
39. Iron and bismuth bound human serum transferrin reveals a partially-opened conformation in the N-lobe.
Yang N; Zhang H; Wang M; Hao Q; Sun H
Sci Rep; 2012; 2():999. PubMed ID: 23256035
[TBL] [Abstract][Full Text] [Related]
40. The molecular mechanism for receptor-stimulated iron release from the plasma iron transport protein transferrin.
Giannetti AM; Halbrooks PJ; Mason AB; Vogt TM; Enns CA; Björkman PJ
Structure; 2005 Nov; 13(11):1613-23. PubMed ID: 16271884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
